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In 2014, about half of children (ages 
18 and younger) in the United States 
were covered by employer-sponsored 
health insurance (ESI) at some point 
during the year.1 Their numbers un-
derscore the importance of under-
standing trends in health care spend-
ing for these children and their use of 
medical services. This report, Chil-
dren’s Health Spending: 2010–2014, is 
the fourth in a series of annual re-
ports from the Health Care Cost Insti-
tute (HCCI) on trends in spending, 
utilization, and price for children’s 
health care.  
For this study, we analyzed a popula-
tion that averaged 10.2 million ESI 
children per year between 2010 and 
2014, the “study period” (see “About 
the Data and Methodology”).2 The 
analytic dataset was weighted to be 
representative of the national popula-
tion of children covered by ESI. As in 
previous studies, HCCI examined the 
per capita health care spending and 
the drivers of health care costs for 
this population of children. This re-
port proceeds in six sections. The first 
section describes the trends for all 
children (ages 0–18) as a group. Sec-
tions two through five examine the 
health care trends for each of the chil-
dren’s age groups: infants and tod-
dlers (ages 0–3), also called “babies”; 
younger children (ages 4–8); pre-
teens (ages 9–13); and teenagers 
(ages 14–18), also called “teens”. The 
final section in this report is new to 
HCCI Children’s Health Spending re-
ports, and details the high-level 
spending per capita and out-of-pocket 
spending per capita trends in ten se-
lected states (which includes the Dis-
trict of Columbia, here referred to as a 
“state”). Additionally, spending for 
each state is compared to the national 
average and interesting trends in chil-
dren’s health care are explored. 
Drivers of Health Care Costs for 
Children 
In 2014, per capita health care spend-
ing for children (see “Key defini-
tions”) covered by ESI was $2,660. 
This was a $90 increase in spending 
over the previous year, an increase of 
3.5%. Over the study period, spending 
per capita for children rose by $477, 
increasing an average annual 5.1% 
(Table 1).  
As observed in previous reports, the 
highest per capita spending in 2014 
was for babies ($4,879), followed by 
teenagers ($2,856), then pre-teens 
($1,940), with the lowest spending 
per capita for younger children 
($1,745). Spending per boy ($2,785) 
also continued to be higher than 
spending per girl ($2,529), although 
spending for girls rose at a faster av-
erage annual rate between 2010 and 
2014: 5.3% for girls and 5.0% for 
boys.  
In every year of the study period, per 
capita spending on each of the sub-
service categories of health care ser-
vices increased (see “Service catego-
ries analyzed in this report”). The 
largest dollar increase between 2010 
and 2014 was observed for profes-
sional services ($171 per capita; Ap-
pendix Table A1). The highest average 
growth rate across the study period 
was for generic prescriptions, which 
grew an average 8.3% per year.  
When analyzing spending trends for 
children, HCCI examined two compo-
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nents that drive changes in expendi-
ture: price and utilization. The aver-
age price per service for each of the 
medical subservice categories in-
creased in each year studied. Howev-
er, the trends in utilization of medical 
services varied over the study period; 
use increased in some years and de-
clined in others. In 2011, use of all 
medical service categories increased 
(Appendix Table A2). In 2012 and 
2013, use of acute inpatient admis-
sions and outpatient visits declined, 
while use of professional services and 
outpatient-other services increased. 
In 2014, use of all medical service 
categories declined. In combination, 
the effects of the price and utilization 
trends on the trends in spending dif-
fered during the study period. In 
2010, increases in both price and uti-
lization drove up health care spend-
ing. In 2011 and 2012, increased 
spending was mainly due to increases 
in average price, but increases in the 
use of some medical services also con-
tributed. By 2014, the largest influ-
ence on the increased spending per 
capita for children was increases in 
average prices, as the use of all medi-
cal subservice categories had de-
clined.  
Trends in price and utilization – and 
their effect on spending – for pre-
scriptions looked different than the 
trends for medical services. The use of 
brand prescriptions declined in every 
year studied. At the same time, the 
average price per filled day more than 
doubled (from $7 per filled day in 
2010 to $16 in 2014). In all years, 
changes in the average price per filled 
day of a brand prescription, rather 
than utilization drove increases in 
spending per capita on brand pre-
scriptions. For generic prescriptions, 
the average price per filled day re-
mained stable at $2 in every year. At 
the same time, use of generic pre-
scriptions increased each year, from 
45,996 filled days of generic prescrip-
tions per 1,000 children in 2010 to 
58,409 filled days in 2014. For gener-
ic prescriptions, increases in both 
price and use contributed to rising 
spending. (Trends for both brand and 
generic prescriptions were influenced 
by many factors, including the expira-
tion of brand patents and the intro-
duction of new brand and generic 
prescriptions into the market, which 
were not controlled for here.) 
In general, the trends in spending, 
price, and utilization described here 
were also observed for each of the 
children’s age groups. The following 
sections detail the specific health care 
trends for each of the age groups, fo-
cusing on total spending per capita, 
out-of-pocket spending per capita, 
utilization of services, and average 
price of services. 
Notable Trends in Children’s 
Health Care 
The following sections of this report 
detail the trends for groups of chil-
dren. While in some ways, the various 
age groups of children are unique 
with their own patterns, a few trends 
are present across the groups. Below 
are a brief discussion of a few of the 
important health care trends ob-
served for children covered by ESI. 
Doctor visits: Of all of the detailed cat-
egories of medical services (see 
“Service categories analyzed in this 
report”), visits to the doctor (both 
office and preventive visits to all pro-
vider types combined) was the single 
type of service with the highest use by 
children during the study period. In 
2014, there were 3,228 visits to the 
doctor per 1,000 children, down 
slightly from the previous year (a 41 
visit per 1,000 children decline) 
(Appendix Table A5). This was also 
where many of the health care dollars 
were spent, on average. In 2014, 
spending on visits to the doctor made 
up 13% of the total per capita spend-
ing for children: $339 per child on 
doctor visits and $2,660 per child on 
all health care services (Appendix 
Table A4). 
ER visits: ER visits are one of the high-
est spending types of services for chil-
dren, and comprised 8% of total 
health care spending per capita for 
children in 2014. Spending on ER vis-
its increased in every year, from per 
capita spending of $165 in 2010 to 
$214 in 2014 (Appendix Table A4). At 
the same time, the number of visits 
declined in 2013 and 2014, to 177 ER 
visits per 1,000 children in 2014 
(Appendix Table A5). 
Prescription use: For the second year 
in a row, the use of prescriptions by 
children declined; the number of 
filled days of prescriptions used by 
children was lower in 2014 than at 
the beginning of the time period in 
2010. There were 72,832 filled days 
per 1,000 children in 2010 and 
72,439 filled days in 2014 (Appendix 
Table A2). The exception to this trend 
of declining prescription use was 
teenagers: use of filled days of pre-
scriptions by teenagers increased in 
every year studied (Appendix Table 
A33). 
Average price of surgical admission: In 
general, the average price per service 
for medical services have increased 
each year that HCCI has studied. In 
this report, the most notable example 
of this – the medical service with the 
largest dollar increase across the 
study period – was the increase in the 
average price of a surgical admission. 
In 2010, the average price was 
$35,423 per surgical admit for chil-
dren, increasing to $53,372 per surgi-
cal admit in 2014 (Appendix Table 
A7). This was a 50% increase in the 
average price in five years. At the 
same time, two things about surgical 
admissions for children should be 
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noted. First, surgical admissions for chil-
dren are relatively rare. For example, a 
use rate of 3 admissions per 1,000 chil-
dren in 2014, as compared to 10 medical 
admissions per 1,000 children that same 
year (Appendix Table A5 and A7). And 
second, the number of these surgical 
admissions declined slightly over the 
study period, from 4 per 1,000 children 
in 2010 to 3 in 2014. 
Out-of-pocket spending on brand pre-
scriptions: Total out-of-pocket spending 
per capita increased each year of the 
study period, at an average annual rate 
of 5.5%. During the study period, out-of-
pocket spending on brand prescriptions 
declined each year, from $40 per child in 
2010 to $30 in 2014 (Appendix Table 
A3). This decline in out-of-pocket spend-
ing tracks the decline in the use of brand 
prescriptions: use declined by 12,816 
filled days per 1,000 children between 
2010 and 2014 (Appendix Table A2). 
However, during the same time period 
total spending per capita on brand pre-
scriptions increased (by $27 per capita; 
Appendix Table A1). These two trends, 
increasing total per capita spending on 
brand prescriptions and declining out-of
-pocket brand prescription spending 
meant that parents were paying a small-
er percentage of spending on brand pre-
scriptions out of pocket in 2014 than 
they were in 2010. Specifically, in 2010, 
21% of all per capita spending on brand 
prescriptions was paid out of pocket, by 
2014, this percentage had fallen to 14% 
(Appendix Tables A1 and A3).  
KEY DEFINITIONS 
Per capita spending: 
Per capita spending in this report is the estimated 
total expenditures on medical and pharmacy claims 
divided by the employer-sponsored insured (ESI) 
population of children. 
Out-of-pocket spending per capita:  
Out-of-pocket spending includes the patient’s share 
of payment for the provision of health care services 
and prescriptions covered by insurance; such 
spending includes any copayments, coinsurance 
payments, or deductible payments. If an insurance 
claim was not filed (e.g., for the purchase of over-the
-counter medicines), the expenditures are not 
included in this metric. These payments also do not 
reflect any refunds, rebates, coupons, or discounts 
that individuals received after making the out-of-
pocket payments. HCCI calculated out-of-pocket 
expenditures per capita by dividing total out-of-
pocket spending by the total insured population of 
children.  
SERVICE CATEGORIES ANALYZED IN THIS REPORT 
In this report, HCCI analyzed medical and 
prescription claims for children (ages 0–18) covered 
by ESI. As in prior reports, HCCI grouped these 
claims into distinct service categories for analytic 
purposes. See the 2014 HCCI Analytic Methodology 
for a detailed description of HCCI’s claims 
categorization methods.2  
Medical service, subservice, and detailed service 
categories in this report 
Three medical service categories were identified: 
inpatient facility, outpatient facility, and professional 
procedures. HCCI also reported on three medical 
subservice categories: acute inpatient admissions, 
which included labor and delivery (LD), newborn, 
surgery , medical, mental health and substance use 
(MH/SU) admissions; outpatient visits; and 
outpatient other services. These are further 
classified into “detailed service” categories.2  
Prescription service, subservice, detailed service 
categories, and therapeutic subclasses in this 
report 
HCCI analyzed prescription claims from retail and 
mail order pharmacies. The prescription service 
category was further classified as branded and 
generic subservice categories. These are further 
classified into “detailed service” categories and 
further into therapeutic subclasses.2 In this report, 
HCCI also examined several therapeutic subclasses 
of prescriptions, as defined by the American Hospital 
Formulary Service (AHFS).2,3  
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In 2014, per capita spending on chil-
dren (ages 0–18) was $2,660, up 3.5% 
($90) over the previous year (Table 1 
and Figure 1). During the study peri-
od (2010–2014), spending grew an 
average annual 5.1%, with the fastest 
growth rate observed in 2010 (7.9%) 
and the slowest in 2014 (3.5%; Ap-
pendix Table A1). 
Among the children’s age groups in 
2014, the highest per capita spending 
($4,879) was for babies (ages 0–3). 
The lowest spending per capita 
($1,745) was for younger children 
(ages 4–8; Appendix Table A1 and 
Figure 2). These trends, of highest 
and lowest spending, were also ob-
served in every year studied. In 2014, 
the highest growth in spending per 
capita (4.9%) was for pre-teens (ages 
9–13); pre-teens also had the highest 
average annual growth (5.9%) during 
the time period. The largest dollar 
increase in spending per capita in 
2014 was for teenagers, whose 
spending grew by $123 to $2,856. 
In all years studied, per capita spend-
ing for boys was higher than for girls. 
For example, in 2014, spending per 
capita for boys was $2,785 compared 
to $2,529 for girls (Appendix Table 
A1). However, spending for girls grew 
at a faster average annual rate across 
the study period: 5.3% average annu-
al growth for girls, as compared to 
5.0% for boys. Conversely, between 
2010 and 2014, there was a slightly 
larger increase in the dollars spent 
per capita for boys ($488) than those 
spent for girls ($466).  
 
 
 
Spending Per Capita 
More dollars were spent on profes-
sional services – 39% of total per cap-
ita spending ($1,039 in 2014) – than 
on any other category of health ser-
vices (Appendix Table A1). Profes-
sional services had the largest in-
crease in the dollars spent per capita 
both in 2014 ($31) and across the 
study period ($171). In 2014, the 
highest per capita spending on a de-
tailed category of services was for 
visits to the doctor: $339 (Appendix 
Table A4). In this report, “visits to the 
doctor” refers to all visits for both 
Health Care Trends: Children 
(Ages 0–18) 
$2,660 
Per capita spending for children  
3.5% 
Increase in spending for children 
$472 
Out-of-pocket per capita spending for 
children 
4.0% 
Increase in out-of-pocket spending 
for children 
-2.0% 
Decrease in the utilization of outpa-
tient visits by children 
6.4% 
Increase in the average price per out-
patient visit for children 
KEY  
FINDINGS: 2014 
ALL CHILDREN (0–18) 
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office and preventive visits to primary 
care providers (PCPs) and specialists.  
Spending per capita on acute inpa-
tient admissions, outpatient-other 
services, and outpatient visits in-
creased at around an average annual 
5% between 2010 and 2014 
(Appendix Table A1). Spending on 
acute admissions (which include 
medical, surgical, newborn, labor and 
delivery, and mental health and sub-
stance use (MH/SU) admissions) 
comprised 23% of total spending per 
child, the second highest spending 
category.  
Spending per capita on acute inpa-
tient admissions, outpatient-other 
services, and outpatient visits in-
creased at around an average annual 
5% between 2010 and 2014 
(Appendix Table A1). Spending on 
acute inpatient admissions (which 
included medical, surgical, newborn, 
labor and delivery, and mental health 
and substance use (MH/SU) admis-
sions) comprised 23% of total spend-
ing per child, the second highest 
spending category ($612 in 2014; 
Table 1).  
Spending on outpatient visits in 2014 
was $414 per capita, comprising 16% 
of total spending on children. ER vis-
its comprised 52% of the spending on 
outpatient visits, or $214 in 2014 
(Appendix Table A4). This spending 
on ER visits was the second highest 
per capita spending of all of the de-
tailed service categories.   
Spending per capita on brand pre-
scriptions also increased in 2014, by 
6.8% ($14 per capita; Table 1). This 
6.8% was the fastest spending growth 
rate observed for any service catego-
ry in that year. In 2013, however, 
spending growth for brand prescrip-
tions was negative, as per capita 
spending on brand prescriptions de-
clined slightly. Much of the 2014 in-
crease in spending on brand prescrip-
tions can be attributed to an increase 
in spending on brand hormones and 
synthetic substitutes, which increased 
by $7 per capita to $53 (Appendix 
Table A4). The hormones and syn-
thetic substitutes category (AHFS 
class 68:00) includes a wide variety of 
prescription types including oral con-
traceptives, parathyroid and pituitary 
medications, and antidiabetic agents 
including insulin.   
The highest average annual growth 
observed during the study period was 
for generic prescriptions, which grew 
an average annual 8.3% (Appendix 
Table A1). Spending increased from 
$105 in 2010 to $145 in 2014. The 
largest portion of this spending in 
2014 was for generic central nervous 
system (CNS) agents ($46 per capita, 
or 32% of total spending on generic 
prescriptions, in 2014) followed by 
generic skin and mucous membrane 
agents ($24 per capita, or 17% of to-
tal spending on generic prescriptions; 
Appendix Table A4). 
 
 
Out-of-Pocket Spending Per Capi-
ta 
In 2014, per capita out-of-pocket 
spending on children (see “Key defini-
tions”) was $472, up 4.0% ($19) over 
the previous year (Appendix Table 
A3). Spending out of pocket rose each 
year in the study period, an average 
annual 5.5%, or $91 between 2010 
and 2014. The highest out-of-pocket 
spending was for babies: $607 per 
baby in 2014 (Figure 2). But this age 
group had the lowest share of costs 
(also called out-of-pocket spending 
burden). Out-of-pocket payments for 
babies comprised just 12.4% of total 
spending for babies (Appendix Table 
A1). In comparison, out-of-pocket 
payments for younger children com-
prised 21.6% of their total spending, 
the highest out-of-pocket spending 
burden, even as the lowest per capita 
out-of-pocket spending was observed 
for younger children (Appendix Ta-
bles A3 and A1).  
This difference in the cost sharing 
burden between babies and younger 
children could partially be due to the 
difference in services that these age 
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groups use. For babies, the most dol-
lars are spent on newborn admissions 
($1,219 per baby in 2014), while out-
of-pocket payments on these admis-
sions are just $68 per baby, or 6% of 
the total on newborn admissions 
(Appendix Tables A3 and A13). For 
younger children, the most dollars are 
spent on ER visits and outpatient sur-
gical visits (both $164 per younger 
child in 2014), while the out-of-
pocket spending is $50 per younger 
child (30% of the total spending on 
ER visits for younger children) and 
$29 (or 18% of the total spending on 
surgical visits), respectively Appendix 
Tables A20 and A3).  
As with total spending, the most dol-
lars spent out-of-pocket were on pro-
fessional services: $231 per capita in 
2014, or nearly 50% of the out-of-
pocket per capita spending. Around 
42% of the dollars spent out of pocket 
on professional services were for vis-
its to the doctor ($97 in 2014; Appen-
dix Table A6). This is the largest por-
tion of the total dollars spent out of 
pocket; 21% of the out-of-pocket 
spending per capita was on visits to 
the doctor. 
During the study period, spending out 
of pocket on professional services has 
seen more moderate growth as com-
pared to the other service categories. 
For example, out-of-pocket spending 
on professional services grew an av-
erage annual 5.5%, as compared to 
average annual growth of 9.6% for 
outpatient visits and 9.0% for outpa-
tient-other services (Appendix Table 
A3). The high growth in out-of-pocket 
spending on outpatient visits is large-
ly attributable to growth in spending 
out of pocket on ER visits, which in-
creased an average annual 11.7% or 
$21 per capita between 2010 and 
2014 (Appendix Table A6). Compara-
tively, out-of-pocket spending on out-
patient surgery visits rose just $6 per 
capita during the study period.  
In comparison to the high growth in 
out-of-pocket spending on the medi-
cal services, spending out of pocket 
declined every year for brand pre-
scriptions. This spending declined an 
average annual 6.8%, falling by $10 
per capita over the study period 
(Appendix Table A3). Mirroring this 
trend in 2014 was generic prescrip-
tions. For the first time in the study 
period, out-of-pocket spending on 
generic prescriptions declined, falling 
from $43 per capita in 2013 to $41 in 
2014. Contributing to this decline in 
spending were $1 per capita decreas-
es in out-of-pocket spending on both 
generic anti-infective agents and ge-
neric respiratory drugs (Appendix 
Table A6).  
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Utilization 
Utilization of outpatient-other ser-
vices, outpatient visits, and brand 
prescriptions declined in 2013 and 
2014 (Appendix Table A2 and Figures 
3 and 4). The number of acute admis-
sions remained stable between 2011 
and 2014. For the first time in the 
study period, the use of professional 
services by children declined in 2014. 
This decrease in the use of profes-
sional services was largely attributa-
ble to fewer visits to the doctor (-41 
visits per 1,000 children to 3,228 vis-
its in 2014), radiology services (-11 
per 1,000 children to 438 services), 
and surgery services (-9 per 1,000 
children to 247 services; Appendix 
Table A5). 
A slight increase in use was observed 
for generic prescriptions; use in-
creased a modest 0.4% in 2014 
(Appendix Table A2 and Figure 4). 
While there was an increase in the 
use of generic prescriptions in all 
years studied, in 2013 and 2014 the 
decline in the use of brand prescrip-
tions was larger than the increase in 
generic prescriptions, leading to a net 
decline in total prescription use in 
those years: total prescription use 
declined by 233 filled days per 1,000 
children in 2013 and 1,691 filled days 
in 2014. 
The most used types of prescriptions 
by children were generic CNS agents 
(17,008 filled days per 1,000 children 
in 2014) and generic anti-infective 
agents (8,537 filled days per 1,000 
children; Appendix Table A5). Use of 
generic CNS agents increased in every 
year studied, an average annual 
11.7%. For generic anti-infective 
agents, however, use declined be-
tween 2012 and 2014.  
Average Price Per Service 
The average price per service in-
creased for all of the medical service 
categories in all years of the study 
period (Appendix Table A2 and Fig-
ure 3). The highest average annual 
growth was for outpatient visits 
(6.5%) followed by acute admissions 
(5.3%). The high growth in average 
price for outpatient visits was not 
limited to one type of visit. All three 
types of outpatient visits (ER visits, 
outpatient surgery, and observation 
visits) had at least 7% average annual 
growth in the average price of a visit 
(Appendix Table A7). For acute ad-
missions, surgical admissions had the 
highest growth, an average annual 
10.8%, followed by medical admis-
sions with 8.8% average growth. 
Comparatively, the lowest growth in 
the average price per service for the 
medical service categories during the 
study period was for professional 
services, an average annual 3.1% 
growth (Appendix Table A2). Price 
growth was moderate for the relative-
ly high priced surgery and anesthesi-
ology professional services; the aver-
age price per service grew an average 
annual 3.4% for professional surgery 
services and 3.1% for anesthesiology 
professional services (Appendix Table 
A7). Higher growth in price was ob-
served for administered drugs, which 
grew an average annual 8.0%, an in-
crease of $102 per service between 
2010 and 2014. 
For both brand and generic prescrip-
tions, the average price per filled day 
increased in nearly every year of the 
study period (Appendix Table A2 and 
Figure 4). The average price of a filled 
day of a brand prescription more than 
doubled, from $7 per day in 2010 to 
$16 per day in 2014. Brand hormones 
and synthetic substitutes had the 
largest observed increase in the aver-
age price for a class of brand prescrip-
tion. The average price of a brand 
hormones and synthetic substitute 
nearly tripled over the study period, 
rising from $9 per filled day in 2010 
to $26 in 2014 (Appendix Table A7).  
The average price per filled day of a 
generic prescription changed little 
over the study period. While it in-
creased in every year between 2011 
and 2014, the average price stayed 
between $2 and $2.49 in every year 
(Appendix Table A2). The highest 
price growth was observed for gener-
ic skin and mucous membrane agents, 
which increased from $3 per filled 
day in 2010 to $5 in 2014 (Appendix 
Table A7). 
www.healthcostinstitute.org 
 
Children’s Health Spending: 2010-2014 5 
 
 
www.healthcostinstitute.org 
 
Children’s Health Spending: 2010-2014 6 
 
Health Care Trends: Infants and Toddlers (Ages 0–3) 
Spending for infants and toddlers 
(“babies”, ages 0–3) was $4,879 per cap-
ita in 2014, an increase of $61 per baby 
over spending in 2013 (Table 2 and Fig-
ure 5). Per capita spending increased 
from $4,041 in 2010 to $4,879 in 2014, 
growing an average annual 4.9% per 
year (Appendix Table A1).  
Babies had the highest per capita health 
care spending of any children’s age 
group. In 2014, spending for babies was 
$4,879 per capita compared to $2,856 
for teenagers, the age group with the 
second highest per capita spending 
(Appendix Table A1). The difference in 
spending between babies and other chil-
dren’s age groups seems to be largely 
due to higher utilization of medical ser-
vices by babies, specifically acute inpa-
tient admissions. For example, there 
were 152 acute inpatient admissions 
per 1,000 babies in 2014 compared to 
26 per 1,000 teenagers. 
In each study year, more dollars per cap-
ita were spent for baby boys than baby 
girls (Appendix Table A8). In 2014, 
spending for baby boys was $5,323 com-
pared to $4,411 for baby girls. While 
spending for baby boys was greater than 
for baby girls in each year, boys and 
girls had similar average annual spend-
ing growth. Average annual spending 
growth for baby boys was 5.1% com-
pared to 4.6% for baby girls.  
Spending Per Capita 
Unlike for other children, where more 
dollars per capita were spent on profes-
sional services than other types of ser-
vices, the most dollars per capita for 
babies were spent on acute inpatient 
admissions (Appendix Table A8 and Fig-
ure 6). Higher spending per capita on 
Snapshot 2014: 
In 2014, the average baby (aged 0–3)… 
 Incurred $4,879 in health care costs 
 The most dollars were spent on newborn hospital admissions followed 
by doctor visits 
 Had 6 doctor visits 
 Had 4 immunizations/injections 
 Used 45 filled days of prescriptions 
 3 days fewer than the previous year 
 The most filled days were generic anti-infectives, specifically generic penicillins (~6 filled 
days) 
 Their parents spent $607 out of pocket 
 The most out-of-pocket dollars were spent on doctor visits and ER visits 
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newborn admissions accounted for 
the higher acute inpatient spending, 
as compared to inpatient spending for 
other age groups (Appendix Table 
A11). 
Between 2010 and 2014, acute inpa-
tient admissions had the highest aver-
age annual growth in spending (5.7%) 
and largest increase in dollars spent 
($394), as compared to the other ma-
jor subservice categories of health 
care services (Appendix Table A8). 
The majority of the dollars spent for 
acute admissions and the reason for 
much of the growth in acute inpatient 
spending was largely due to newborn 
admissions. In 2014, spending on 
newborn admissions was $1,219 per 
baby, and between 2010 and 2014, 
there was average annual spending 
growth of 6.9% and an increase of 
$286 (Appendix Table A11). 
The subservice category with the sec-
ond highest per capita spending for 
babies was professional services: 
$1,912 per capita in 2014 (Appendix 
Table A8 and Figure 6). Professional 
services also had the second largest 
increase in dollars spent per capita 
between 2010 and 2014 ($305), after 
acute admissions ($394). About one 
third of the dollars spent on profes-
sional services were for doctor visits 
(Appendix Table A11). Spending was 
$631 per baby in 2014, and increased 
by $77 per baby over the study peri-
od. 
Spending per capita on all outpatient 
services for babies was $801 in 2014, 
$537 of which was spent on outpa-
tient visits and $264 on outpatient-
other services (Appendix Table A8 
and Figure 6). Similarly, over the 
study period, spending on babies’ out-
patient visits increased by $89, while 
spending on outpatient-other services 
increased by $49. Of the $537 per ba-
by spent on outpatient visits in 2014, 
$265 was spent on ER visits and $254 
was spent on outpatient surgery vis-
its, while just $19 was on observation 
visits (Appendix Table A11). 
In 2014, prescription per capita 
spending was $168, of this amount 
$85 was on brand prescriptions and 
$83 on generics. Spending on brand 
prescriptions increased slightly be-
tween 2010 and 2014, by $7 per capi-
ta; however, spending per capita on 
generic prescriptions declined over 
the study period, by $2 per capita to 
$83 per baby (Appendix Table A8). 
Out-of-Pocket Spending Per Capi-
ta 
Out-of-pocket per capita spending for 
babies was $607 in 2014, and in-
creased by $104 from 2010 to 2014 
(Appendix Table A10). During this 
same period, out-of-pocket spending 
grew an average annual 4.8% per 
year, a slightly slower average rate 
than for total spending (4.9%; Appen-
dix Table A8). 
While the most dollars per capita for 
babies were spent on inpatient ser-
vices (Appendix Table A8), the most 
out-of-pocket dollars were spent on 
professional services ($291 in 2014; 
Appendix Table A10 and Figure 6). Of 
the out-of-pocket spending for babies 
on professional services, nearly half 
was spent on doctor visits ($144 in 
2014).  
Out-of-pocket per capita spending for 
babies on acute inpatient admissions 
was largely driven by newborn ad-
missions, the same driver of acute 
inpatient per capita spending. Of the 
$92 per baby spent out of pocket on 
acute inpatient admissions in 2014, 
$68 was spent on newborn admis-
sions (Appendix Table A13). 
Total outpatient out-of-pocket spend-
ing was $178 per baby in 2014, $129 
of which was for outpatient visits and 
$49 for outpatient-other services 
(Appendix Table A10 and Figure 6). 
Most of the outpatient out-of-pocket 
spending was on ER visits ($80 in 
2014). ER visits had the second high-
est out-of-pocket spending of all of 
the detailed categories after visits to 
the doctor (Appendix Table A13).  
Across the study period, the fewest 
dollars spent out of pocket on a sub-
service category were for prescrip-
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tions. In 2014, out-of-pocket spending 
on prescriptions was $46, of this 
amount $15 was spent on brand pre-
scriptions compared to $32 on gener-
ics (Appendix Table A10). Out-of-
pocket spending on brand prescrip-
tions declined in every year of the 
study period, from $20 per baby in 
2010 to $15 in 2014. Spending out of 
pocket on generic prescriptions in-
creased between 2010 and 2012 
(from $35 per baby to $37), before 
declining in 2013 and 2014 (from $37 
per baby to $32). 
Utilization 
Acute inpatient admissions increased 
over the study period from 145 ad-
missions per 1,000 babies in 2010 to 
152 admissions per 1,000 babies in 
2013, and were steady in 2014 
(Appendix Table A9 and Figure 7). Of 
the 152 admissions per 1,000 babies 
in 2014, 125 were for newborn ad-
missions (Appendix Table A12). 
While medical admissions were the 
most common type of acute inpatient 
admissions for younger children 
(medical admissions comprised 
72.7% of total acute admissions by 
younger children in 2014; Appendix 
Table A19) and pre-teens (50.0% of 
total acute admissions in 2014; Ap-
pendix Table A26), medical admis-
sions were just 14.5% of total acute 
admissions for babies (Appendix Ta-
ble A12). 
Between 2011 and 2014, the use of 
outpatient services by babies declined 
(Appendix Table A9 and Figure 7). 
Outpatient-other service use declined 
from 1,401 services per 1,000 babies 
in 2011 to 1,348 in 2014, and the uti-
lization of most types of outpatient-
other services also declined (i.e., out-
patient radiology and outpatient la-
boratory/pathology; Appendix Table 
A12). Between 2011 and 2014, the 
number of outpatient visits declined 
from 365 visits per 1,000 babies to 
341 visits (Appendix Table A9). ER 
visits declined in each year after 
2012, declining from 285 per 1,000 
babies in 2012 to 272 per 1,000 ba-
bies in 2014 (Appendix Table A12). 
There were 20,242 professional ser-
vices per 1,000 babies in 2014 
(Appendix Table A9). Visits to doctors 
accounted for nearly 30% of these 
professional services for babies, 6,032 
doctor visits per 1,000 babies in 2014 
(Appendix Table A12). The total num-
ber of doctor visits declined slightly 
over the study period, from 6,210 
visits per 1,000 babies in 2010 to 
6,032 in 2014. However, this decline 
was only for office visits to primary 
care providers (PCPs), which declined 
from 3,359 visits per 1,000 babies in 
2010 to 2,868 in 2014. Over the same 
time period, preventive visits and 
visits to specialists increased slightly. 
Another frequently used service dur-
ing the study period for babies was 
the administration of drugs, or the 
injections administered to babies. 
While the number of services fell 
slightly in 2014 (by 61 injections per 
1,000 babies), there were 3,686 injec-
tions per 1,000 babies in 2014. 
Babies had the lowest prescription 
use of all of the children’s age groups 
and use appeared to increase with 
age. In 2014, babies had the lowest 
use at 45,351 filled days per 1,000 
babies (Appendix Table A9), com-
pared to 50,594 filled days for young-
er children (Appendix Table A16), 
68,265 for pre-teens (Appendix Table 
A23), and 111,654 for teenagers 
(Appendix Table A33). 
In each year of the study period, ba-
bies had more filled more days of ge-
neric prescriptions than brand pre-
scriptions. In 2014, of the 45,531 
filled days per 1,000 babies, 39,651 
filled days were generic prescriptions 
compared to 5,664 filled days that 
were brand prescriptions (Appendix 
Table A9). Babies had the most filled 
days of generic anti-infective agents 
(11,416 filled days per 1,000 babies; 
Appendix Table A12), compared to 
other age groups, such as pre-teens, 
who had the most days filled days of 
generic central nervous system (CNS) 
agents (Appendix Table A26). The 
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most common type of generic pre-
scription used by babies was generic 
penicillins (AHFS class 08:12.16) with 
6,395 filled days per 1,000 babies in 
2014 (Appendix Table A51). The sec-
ond most common in 2014 was ge-
neric histamine H-2 antagonists 
(AHFS class 56:28.12; gastrointestinal 
drugs, for example famotidine, which 
is used to treat excess stomach acid) 
with 3,636 filled days per 1,000 ba-
bies.  
Average Price Per Service 
The average price per service in-
creased across all major medical and 
brand prescriptions between 2010 
and 2014 (Appendix Table A9). The 
highest average price per service was 
for acute admissions at $13,122 per 
admission in 2014, followed by outpa-
tient visits at $1,575 per visit. The 
lowest average price per service was 
for professional services ($94 per 
service) and brand prescriptions ($15 
per filled day). Similarly, over the 
study period, the largest increase in 
the average price per service was for 
acute admissions (an increase of 
$2,069 per admission) followed by 
outpatient visits (an increase of $334 
per visit).  
The average price per acute inpatient 
admission grew in each year of the 
study period. The highest average 
price and the largest increase in aver-
age price was observed for surgical 
admissions (Appendix Table A14). 
The average price per surgical admis-
sion was $76,405 in 2014, an increase 
of $18,076 over the average price in 
2010.  
The average price per professional 
service was $94 in 2014, an increase 
of $14 per service over 2010 ($80; 
Appendix Table A9). The highest av-
erage price per service within the 
professional services was for anesthe-
sia, with an average price of $631 per 
service in 2014 (Appendix Table 
A14).  
As with other major medical catego-
ries, the average price for an outpa-
tient visit increased in each year stud-
ied, growing from $1,241 in 2010 to 
$1,575 in 2014 (Appendix Table A9). 
Of the three types of outpatient visits, 
the highest average price and the 
largest increase in average price over 
the study period were for outpatient 
surgical visits. The average price per 
surgical visit was $4,333 in 2014, and 
increased by $1,082 over 2010 
(Appendix Table A14). 
The average price per filled day of a 
brand prescription grew dispropor-
tionally to that of generic prescrip-
tions during the study period. The 
average annual growth in brand pre-
scriptions was 24.7% with the aver-
age price per filled day more than 
doubling from $6 per filled day in 
2010 to $15 in 2014 (Appendix Table 
A9). For generic prescriptions, the 
average annual price growth was just 
0.6%.  
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Health Care Trends: Younger Children (Ages 4–8) 
During the study period (2010-2014), 
younger children (ages 4–8) had the 
lowest per capita spending of any 
children’s age group: $1,745 in 2014 
(Table 3, Appendix Table A15, and 
Figure 8). Younger children also had 
lower growth in spending as com-
pared to the other groups: average 
annual growth of 4.1%. This trend of 
lower per capita spending for young-
er children than for the other age 
groups is mainly due to lower medical 
service utilization, as compared to 
other children. For example, younger 
children used 11 acute inpatient ad-
missions and 1,054 outpatient ser-
vices in 2014 (Appendix Table A16), 
while teenagers used 26 admissions 
and 1,398 outpatient services 
(Appendix Table A33).  
Spending Per Capita 
In 2014, the most spending per capita 
for younger children was on profes-
sional services followed by outpatient 
visits (Table 3). Of the total spending 
per capita for these children, 45% 
($779) was on professional services, 
while just 19% ($338) was on outpa-
tient visits. Spending on professional 
services also saw the largest increase 
in per capita dollars spent on younger 
children both in 2014 (an increase of 
$21) and across the study period (an 
increase of $112).  
Of the $779 dollars spent per capita 
on professional services in 2014, 
$290 (37% of professional spending) 
was spent on visits to the doctor 
(Appendix Table A18). In 2014, $338 
was spent on outpatient visits. Of this 
outpatient visits spending, $164 was 
spent on both ER visits and outpatient 
surgery. 
The lowest spending subcategories of 
health care services for younger chil-
Snapshot 2014: 
In 2014, the average younger child (aged 4–8)… 
 Incurred $1,745 in health care costs 
 The most dollars were spent on doctor visits, ER visits, and outpatient 
surgery 
 Had 3 doctor visits 
 Had 1 immunizations/injections 
 Used 51 filled days of prescriptions 
 3 days fewer than the previous year 
 The most filled days were generic anti-infectives 
 Their parents spent $377 out of pocket 
 The most out-of-pocket dollars were spent on doctor visits and ER visits 
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dren were prescriptions in all years of 
the study period. For example, in 
2014, $132 per capita was spent on 
brand prescriptions, a $2 increase 
over the previous year (Appendix 
Table A15). For generic prescriptions, 
$98 was spent per capita, the same 
amount as the previous year.  
For brand prescriptions, in 2014 $30 
per capita (23% of the dollars spent 
on brand prescriptions) was spent on 
brand CNS agents, while $22 per capi-
ta (17% of the dollars spent on brand 
prescriptions) was spent on brand 
respiratory agents (Appendix Table 
A18). Of the $98 spent per younger 
child in 2014 on generic prescrip-
tions, the most dollars ($24 per capi-
ta) were spent on both generic CNS 
agents and generic anti-infective 
agents.  
Out-of-Pocket Spending Per Capi-
ta 
During the study period, younger chil-
dren had the lowest per capita out-of-
pocket spending of any of the chil-
dren’s age groups. For example, $377 
was spent out of pocket per younger 
child in 2014 (Appendix Table A17). 
However, younger children had the 
highest out-of-pocket burden, as 
measured through the percentage of 
total spending per capita that was 
paid out of pocket (Appendix Tables 
A15 and A17). Parents of younger 
children paid 21.6% of the total 
spending out-of-pocket, a higher 
share than for any other age group. 
Out-of-pocket spending for younger 
children per capita grew faster during 
the study period than did total spend-
ing for younger children: an average 
annual 5.3% and 4.1%, respectively 
(Appendix Tables A15 and A17). Out-
of-pocket per capita spending in-
creased by $70 between 2010 and 
2014, as compared to an increase of 
$256 in total spending. As with total 
spending per capita, the most out of 
pocket dollars were spent on profes-
sional services: $194 in 2014. Of that 
amount, $89 per younger child, or 
46% of the out-of-pocket spending on 
professional services in 2014, was on 
visits to the doctor (Appendix Table 
A20).  
We observed high growth in out-of-
pocket spending on outpatient visits 
during the study period, an average 
annual 10.3% growth (Appendix Ta-
ble A17). Spending out of pocket on 
outpatient visits per younger child 
grew from $55 in 2010 to $81 in 2014 
(Figure 9). Nearly half of those out-of-
pocket dollars on visits (43%) were 
on ER visits ($50 per capita in 2014; 
Appendix Table A20). Comparatively, 
out-of-pocket spending on outpatient 
surgery visits was $29 per capita in 
2014.  
The least spending during the study 
period out-of-pocket for younger chil-
dren was on acute admissions. In 
2014, $11 per younger child was 
spent out of pocket on acute admis-
sions (Appendix Table A17). Growth 
of out-of-pocket spending on acute 
admissions was fairly flat during the 
study period, increasing from $9 to 
$11 per capita (Figure 9).  
During every year of the study period 
for brand prescriptions, and in 2014 
for generic prescriptions, out-of-
pocket spending for younger children 
declined. Spending out of pocket on 
brand prescriptions declined from 
$33 per younger child in 2010 to $22 
in 2014.  
Utilization 
The utilization trends for younger 
children resembled those observed 
for babies during the study period. In 
2014, utilization of outpatient ser-
vices, professional services, and pre-
scriptions declined, and the number 
of acute admissions was the same as 
the previous year (Appendix Table 
A16).  
Across the medical services in 2014, 
the declines in use were fairly small. 
The largest decline in use was ob-
served for visits to the doctor; in 
2014, the number of visits to the doc-
tor declined by 53 to 2,788 visits per 
1,000 younger children (Appendix 
Table A19). This was the third year in 
a row that the number visits to the 
doctor declined. At the same time, 
there was a small decline in the num-
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ber of injections administered to 
younger children (“administration of 
drugs”); in 2014, there were 923 in-
jections per 1,000 younger children, 
down 10 injections over the previous 
year. 
Across the time period, there was a 
large decline in the use of brand pre-
scriptions (Appendix Table A16 and 
Figure 10). Brand prescription use 
declined by 13,564 filled days per 
1,000 younger children between 2010 
and 2014. The most used types of 
brand prescriptions were brand CNS 
agents (3,003 filled days per 1,000 
younger children in 2014) and respir-
atory drugs (2,832 filled days; Appen-
dix Table A19). Use of all subcatego-
ries of brand prescriptions generally 
declined over the study period. The 
largest declines in use were for brand 
respiratory drugs (a decline of 3,447 
filled days per 1,000 younger chil-
dren) and brand CNS agents (a de-
cline of 2,197 filled days). 
In 2014, for the first time, the use of 
generic prescriptions by younger chil-
dren declined (Appendix Table A16 
and Figure 10). Use declined by 914 
filled days per 1,000 younger chil-
dren. The most used subcategory of 
generic prescriptions during the 
study period was generic anti-
infective agents (7,444 filled days per 
1,000 younger children in 2104), fol-
lowed by generic CNS agents (7,137 
filled days; Appendix Table A19). In-
terestingly, use of generic anti-
infective agents declined between 
2011 and 2014 (a decline of 1,677 
filled days per 1,000 younger children 
between 2011 and 2014), while use of 
generic CNS agents increased be-
tween 2010 and 2013 (an increase of 
2,015 filled days between 2010 and 
2013).  
The most used type of prescriptions 
by younger children was generic leu-
kotriene modifiers (AHFS class 
48:10.24) with 5,341 filled days per 
1,000 younger children in 2014 
(Appendix Table A52) . Leukotriene 
modifiers are a type of respiratory 
agent commonly used to manage the 
symptoms of allergies and mild-to-
severe asthma. The second most used 
type of prescription was generic peni-
cillins (AHFS class 08:12.16) with 
4,076 filled days per 1,000 younger 
children. 
While use of generic prescriptions 
increased between 2010 and 2013, 
this did not offset the large declines in 
use of brand prescriptions throughout 
the study period. The result of this 
was a net decline in the use of all pre-
scriptions in every year of the study 
period; use declined from 55,964 
filled days of prescriptions per 1,000 
younger children in 2010 to 50,594 
filled days in 2014 (Appendix Table 
A16). Much of that decline is attribut-
able to a decline in the use of both 
brand and generic hormones and syn-
thetic substitutes. Between 2010 and 
2014, use of brand and generic hor-
mones and synthetic substitutes pre-
scriptions declined by 3,610 filled 
days per 1,000 younger children 
(Appendix Table A19). 
Average Price Per Service 
The average price per service for each 
of the medical service categories in-
creased in all years of the study peri-
od (Appendix Table A16). The largest 
dollar increase in average price and 
the highest average annual growth 
rate was for acute inpatient admis-
sions. The average price of an acute 
admission grew an average annual 
7.5%, and increased by $5,196 be-
tween 2010 and 2014. The sizable 
increase in the average price per ad-
mission was largely due to the in-
crease in the average price of a surgi-
cal admission, which rose from 
$29,489 in 2010 to $42,168 in 2014 
(Appendix Table A21).  
In contrast to the trend for acute ad-
missions, the average price per ser-
vice for outpatient-other services and 
professional services had much small-
er increases; the average price per 
service increased just $34 for outpa-
tient-other services and $10 for pro-
fessional services over the study peri-
od (Appendix Table A16). The aver-
age price of an outpatient visit rose by 
$337 during the study period. Much of 
this increase was due to a $1,005 in-
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crease in the average price per outpa-
tient surgery during that time. 
The average price per filled day of a 
brand prescription more than dou-
bled over the course of the study peri-
od: rising from $6 in 2010 to $13 in 
2014. This increase in the average 
price was partially attributable to 
increases in the average price per day 
of brand anti-infective agents – which 
doubled during the study period 
(from $13 in 2010 to $26 in 2014) – 
and brand hormones and synthetic 
substitutes, which nearly quadrupled 
(from $7 to $27; Appendix Table 
A21). 
The average price per filled day of a 
generic prescription, however, moved 
very little during the study period. 
The average price per filled day re-
mained between $2 and $2.49 in each 
year (Appendix Table A16). The aver-
age price per filled day of most sub-
categories of generic prescriptions 
stayed between $1 and $3 during the 
study period. However, the average 
price per filled day of generic hor-
mones and synthetic substitutes de-
clined by $4: from $6 per filled day in 
2010 to $2 in 2014 (Appendix Table 
A21).  
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Health Care Trends: Pre-Teens (Ages 9–13) 
In 2014, per capita spending for pre-
teens (ages 9–13) was $1,940, an in-
crease of $90 over 2013 (Table 4 and 
Figure 11). Pre-teens had the second 
lowest spending of any of the chil-
dren’s age groups. However, pre-teen 
spending exhibited the largest aver-
age annual growth (growing an aver-
age 5.9% per year) over the study 
period as compared to other age 
groups (Appendix Table A1).  
While spending per capita grew 
across the study period for both pre-
teen girls and boys, spending per boy 
was higher than spending per girl in 
each year. For example, in 2014, 
spending was $2,051 per boy com-
pared to $1,825 per girl (Appendix 
Table A22). Even with higher spend-
ing for boys, spending for girls grew 
at a faster average annual rate: 6.5% 
per year for girls and 5.5% per year 
for boys. 
Over the study period, pre-teen per 
capita spending increased each year 
for all major categories of health care 
services. These spending increases 
were due to increases in average 
price per service, and price increases 
were not offset by changes in utiliza-
tion, as explored below. 
Spending Per Capita 
Professional services represented the 
largest spending category out of all 
the major categories in all years 
(Figure 12). For example, per capita 
spending in 2014 on professional ser-
vices was $780, or 40% of total 
spending for pre-teens. Spending on 
these services increased across the 
study period, an increase of $144 per 
pre-teen between 2010 and 2014. 
Within professional services, the larg-
est portion of spending was on mis-
cellaneous services (e.g., physical 
therapy), which was 39% of spending 
on all professional services in 2014 
Snapshot 2014: 
In 2014, the average pre-teen (aged 9–13)… 
 Incurred $1,940 in health care costs 
 The most dollars were spent on doctor visits and ER visits 
 Had 2 doctor visits 
 Had 1 laboratory or pathology procedure  
 Used 68 filled days of prescriptions 
 2 days fewer than the previous year 
 The most filled days were generic central nervous system and cerebral stimulants 
 Their parents spent $392 out of pocket 
 The most out-of-pocket dollars were spent on doctor visits and ER visits 
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(Appendix Table A25). This was fol-
lowed by spending on doctor visits, 
which comprised 34% of professional 
spending. Spending on doctor visits 
increased over the study period by 
$52 per pre-teen to $263 in 2014.  
In 2014, spending for pre-teens on 
acute admissions was $273, the low-
est per capita spending on acute ad-
missions for any children’s age group 
(Appendix Table A22 and Figure 12). 
Acute inpatient spending per capita 
increased by $65 over the study peri-
od, growing an average annual 7.4%. 
The majority of inpatient acute 
spending was on surgical ($128 per 
pre-teen) and medical ($115) admis-
sions (Appendix Table A25).  
Spending per capita on all outpatient 
services in 2014 was $488. Of the 
spending on outpatient services, $301 
was spent on outpatient visits and 
$187 on outpatient-other services 
(Appendix Table A22 and Figure 12). 
Per capita spending on outpatient 
visits increased by $15 in 2014. Of 
this $15 increase, $13 was on ER vis-
its and $2 on outpatient surgery 
(Appendix Table A25).   
Prescription per capita spending was 
$398 in 2014, of this 64% ($253) was 
on brand prescriptions and 36% 
($145) was on generic prescriptions 
(Appendix Table A22 and Figure 12). 
Spending on both brand and generic 
prescriptions increased in each year 
studied, with a larger increase over 
the study period in spending on ge-
neric prescriptions ($56) than brand 
prescriptions ($34). 
The most dollars spent on a drug class 
for both generic and brand prescrip-
tions was on CNS agents: $65 on ge-
neric CNS agents and $81 on brand 
CNS agents in 2014 (Appendix Table 
A25). A CNS agent is a drug category 
which includes central nervous sys-
tem stimulants (which may be used to 
treat attention deficit hyperactivity 
disorder (ADHD)), antidepressants, 
and anti-anxiety medications.  
Out-of-Pocket Spending Per Capi-
ta 
Out-of-pocket spending for pre-teens 
was $392 in 2014, and increased in 
each year studied (Appendix Table 
A24). As with total spending, pre-
teens had higher growth in out-of-
pocket spending across the study pe-
riod than the other age groups. Out-of
-pocket spending for pre-teens grew 
an average annual 6.1% during the 
study period. 
Of the $392 spent out of pocket for 
pre-teens in 2014, $12 was on acute 
inpatient admissions, $109 on all out-
patient services, $196 on professional 
services, and $74 on prescriptions. 
Professional services represented the 
largest proportion (50%) of out-of-
pocket dollars spent. The most pro-
fessional out-of-pocket dollars were 
spent on visits to the doctor ($81 in 
2014), and spending on doctor visits 
grew by $17 per pre-teen over the 
study period (Appendix Table A27).  
Acute inpatient out-of-pocket spend-
ing was fairly stable during the study 
years, growing just $2 over the time 
period (Appendix Table A24). The 
largest share of acute admission out-
of-pocket spending was attributed to 
medical admissions (Appendix Table 
A27). On average in 2014, pre-teens 
spent $12 out-of-pocket on inpatient 
care, and $6 of this was spent on med-
ical admissions (Appendix Table 
A24).  
Out-of-pocket spending on outpatient 
services grew each year studied, and 
both outpatient visits and outpatient-
other services had higher growth than 
other medical service categories. Out-
of-pocket spending grew an average 
annual 10.2% for outpatient visits 
and 9.6% for outpatient-other ser-
vices. The most outpatient out-of-
pocket dollars were spent on ER vis-
its. In 2014, $46 per pre-teen was 
spent out of pocket on ER visits, 
which comprised 42% of all outpa-
tient out-of-pocket spending 
(Appendix Table A27). 
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Brand and generic out-of-pocket ex-
penditures followed opposing trends 
across the study period. Brand out-of-
pocket spending decreased in each 
year, declining by $11 across the 
study period. Between 2010 and 
2013, generic out-of-pocket spending 
increased (by $13) before declining 
by $1 in 2014 (Appendix Table A24). 
In 2010, out-of-pocket spending was 
higher on brand prescriptions ($45) 
than on generic prescriptions ($28). 
Conversely, in 2014, out-of-pocket 
spending on generic prescriptions 
($40) was higher than on brand pre-
scriptions ($34). Similar to the total 
spending on prescriptions, the most 
dollars spent out of pocket for both 
brand and generic prescriptions was 
attributable to spending on CNS 
agents (Appendix Table A27).  
Mirroring trends in total prescription 
spending per capita, out-of-pocket 
expenditures on prescriptions were 
higher for pre-teen boys than girls. 
For example, in 2014, out-of-pocket 
spending on all prescriptions for pre-
teen girls was $28 as compared to $60 
for boys, this gender difference was 
also true for both brand and generic 
prescriptions (Appendix Table A24).   
Utilization 
Trends in the utilization of services by 
pre-teens varied by major medical 
category. For example, over the study 
period use of inpatient admissions 
remained stable, while outpatient 
visits declined, and use of profession-
al services increased (Appendix Table 
A23). 
As observed for the other children’s 
age groups, the number of acute inpa-
tient admissions were fairly con-
sistent across the study period. Be-
tween 2010 and 2012, there were 13 
inpatient acute admissions per 1,000 
pre-teens, compared to 12 acute ad-
missions in 2013 and 2014 (Appendix 
Table A23). Of the 12 admissions per 
1,000 pre-teens in 2014, 6 were medi-
cal admissions, while 3 each were 
MH/SU admissions and surgical ad-
missions (Appendix Table A26). 
Over the study period, there was a 
slight decline in outpatient visits, a 
trend also observed in the other age 
groups (Appendix Table A23). Within 
outpatient visits, ER utilization saw 
the greatest decline of 6 visits per 
1,000 pre-teens between 2010 and 
2014, as compared to a decline of 2 
outpatient surgical visits (Appendix 
Table A26). 
Pre-teens used more professional 
services than any other type of medi-
cal service, and use increased in each 
year studied (Appendix Table A23). 
This trend of increasing use was not 
true for all children’s age groups, as 
both babies and younger children saw 
declining professional service utiliza-
tion in recent years. However, while 
pre-teens’ use of professional services 
increased each year, the rate of utili-
zation growth slowed with each pass-
ing year.  
Pre-teens had more visits to the doc-
tor than use of any other type of pro-
fessional service: 2,481 visits per 
1,000 pre-teens in 2014 (Appendix 
Table A26). The number of visits in-
creased slightly over the study period, 
by 145 visits per 1,000 pre-teens. 
In 2014, the number of filled days of 
prescriptions was 68,265 per 1,000 
pre-teens, a small decrease (-2,022) 
in use over the previous year 
(Appendix Table A23). Each year be-
tween 2010 and 2014, the proportion 
of generic to brand prescription filled 
days increased (Figure 13). In 2010, 
45% of all filled days per 1,000 pre-
teens were brand prescriptions as 
compared to 55% that were generic. 
In 2014, 24% of all filled days per 
1,000 pre-teens were brand prescrip-
tions as compared to 76% that were 
generics. One reason for this trend 
was declining use of brand prescrip-
tions over the study period (-14,352 
filled days between 2010 and 2014). 
At the same time, use of generics in-
creased by 14,964 filled days per 
1,000 pre-teens over the study peri-
od.  
While pre-teen boys and girls had 
similar utilization of medical services, 
boys had more filled days of prescrip-
tions per 1,000 pre-teen boys than 
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pre-teen girls: 79,833 filled days per 
1,000 boys in 2014 as compared to 
56,140 filled days per 1,000 girls 
(Appendix Tables A30 and A31). This 
trend was also true of use of CNS 
agents; in 2014, boys used twice as 
many filled days of CNS agents 
(38,368 filled days per 1,000 boys) 
than girls (18,939 filled days).  
The most used type of prescriptions 
for pre-teens were generic respirato-
ry and cerebral stimulants (AHFS 
class 28:20.32; a class of drugs that 
includes ADHD drugs, such as Ritalin) 
with 7,516 filled days per 1,000 pre-
teens (Appendix Table A53). The sec-
ond most used type of prescription 
was generic antidepressants (AHFS 
class 28:16.04) with 5,129 filled days 
per 1,000 pre-teens. 
Average Price Per Service 
Over the study period, the average 
price per service increased across all 
medical service categories in each 
year (Appendix Table A23). The larg-
est change in average price was for 
acute inpatient admissions, the aver-
age price of which grew from $16,327 
in 2010 to $22,218 in 2014. The 
smallest change in average price per 
medical service was for professional 
services, a change of $8 per service 
over the study period. 
The average price per outpatient visit 
was $1,837 in 2014, an increase of 
$451 since 2010 (Appendix Table 
A23). This increase was influenced by 
a $325 increase in the average price 
per ER visit over the study period and 
a $1,162 increase in the average price 
of a surgical visit (Appendix Table 
A28). 
Over the study period, the average 
price per filled day of a prescription 
increased more for brand prescrip-
tions than for generics (Appendix Ta-
ble A23).  While the average price 
paid per filled day for a generic pre-
scription remained relatively constant 
across years ($2 in 2010 and $3 in 
2011 through 2014; numbers round-
ed to nearest whole dollar), the aver-
age price paid per filled day of a 
brand prescription more than dou-
bled from $7 in 2010 to $16 in 2014. 
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Health Care Trends: Teenagers (Ages 14–18) 
Teenagers (ages 14–18) had the sec-
ond highest per capita spending of 
any children’s age group: $2,856 per 
teenager in 2014 (Table 5 and Figure 
14). Also in 2014, spending increased 
by 4.5%, or $123 per teenager. This 
was the largest dollar increase for any 
age group in that year. Over the whole 
study period, spending for teenagers 
grew an average annual 5.2%, and 
increased $527 between 2010 and 
2014 (Appendix Table A32).  
Teenagers are the only group of chil-
dren for whom per capita spending is 
higher for girls than for boys. In 2014, 
spending was $2,949 for girls and 
$2,766 for boys (Table 5). This differ-
ence was largely due to higher utiliza-
tion of all service categories by teen 
girls as compared to teen boys, specif-
ically use of generic prescriptions and 
professional services (Appendix Table 
A40). Only spending on brand pre-
scriptions was higher for boys than 
for girls: $412 per teen boy and $273 
per teen girl (Appendix Table A39). At 
the same time, utilization of brand 
prescriptions was slightly higher for 
girls than for boys: 21,098 filled days 
per 1,000 teen girls and 19,481 filled 
days per 1,000 teen boys (Appendix 
Table A40). The higher per capita 
spending on brand prescription for 
boys was due to a higher average 
price per filled day, $21 per day for 
teen boys as compared to $13 per day 
for teen girls. 
Spending Per Capita 
For teenagers, spending per capita on 
all subservices categories increased in 
all of the years studied. In 2014, 
spending per teenager on profession-
al procedures was nearly double 
spending on any other subservice 
Snapshot 2014: 
In 2014, the average teen (aged 14–18)… 
 Incurred $2,856 in health care costs 
 The most dollars were spent on doctor visits and ER visits 
 Had 3 doctor visits 
 Had 2 laboratory or pathology procedure  
 Used 112 filled days of prescriptions 
 ~1/2 day more than the previous year 
 For boys, the most filled days were generic antidepressants 
 For girls, the most filled days were generic oral contraceptives 
 Their parents spent $551 out of pocket 
 The most out-of-pocket dollars were spent on doctor visits and ER visits 
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category ($1,005 per teen), and made 
up 35% of the total spending for teen-
agers (Appendix Table A32). Profes-
sional services also had the highest 
dollar growth over the previous year 
($33). The second most spending was 
on outpatient visits ($518 per teen), 
which was the subservice category 
that also had the second highest dol-
lar growth over the previous year 
($28). Within these two high-
spending categories of services, the 
most dollars were spent on visits to 
doctors ($283 per teen in 2014), ER 
visits ($271 per teen), and outpatient 
surgical visits ($233 per teen; Appen-
dix Table A35). 
We also observed small year-on-year 
dollar increases and steady growth 
throughout the study period in spend-
ing on outpatient-other services and 
acute admissions. Spending per teen 
on outpatient-other services in-
creased from $237 in 2010 to $300 in 
2014, while spending on acute admis-
sions increased over that time period 
by $82. Of the types of acute admis-
sions, the most dollars were spent on 
surgical admissions: $190 per teenag-
er in 2014 (Appendix Table A32). 
Spending on surgical admissions rose 
throughout the time period, from 
$161 in 2010 to $190 in 2014 
(Appendix Table A35). 
Spending per capita on brand and 
generic prescriptions was lower than 
spending on most other categories of 
services. Spending on brand and ge-
neric prescriptions comprised just 
under 20% of the total per capita 
spending for teenagers ($344 on 
brand prescriptions and $221 on ge-
nerics in 2014; Appendix Table A32). 
For both brand and generic prescrip-
tions, spending increased in every 
year studied; increasing an average 
annual 4.6% for brand and 9.4% for 
generics.  
Among the types of brand prescrip-
tions, in 2014, the most dollars were 
spent on brand hormones and syn-
thetic substitutes ($96 per teen), fol-
lowed by brand CNS agents ($83; Ap-
pendix Tables A35). For generic pre-
scriptions, spending per capita was 
highest for generic CNS agents ($73 
per teen), followed by generic skin 
and mucous membrane agents ($58 
per teen). An example of a commonly 
used generic skin and mucous mem-
brane agent would be topical antibac-
terials, such as those used to treat 
acne (e.g., dapsone).  
Out-of-Pocket Spending Per Capi-
ta 
Out-of-pocket spending for teens in-
creased in every year studied, in-
creasing $106 per teen between 2010 
and 2014 (Appendix Table A34). This 
was the largest dollar increase in out-
of-pocket spending observed for any 
of the children’s age groups. Out-of-
pocket spending grew an average an-
nual 5.5% during the study period, 
rising to $551 per capita in 2014.  
As with total spending for teenagers, 
the most out-of-pocket dollars per 
capita were spent on professional 
services and outpatient visits. Be-
tween 2010 and 2014, out-of-pocket 
spending on professional services 
grew by $56 per capita (an average 
annual 6.2% growth; Appendix Table 
A34). There was also high out-of-
pocket spending growth on outpa-
tient visits during the study period, an 
average annual 9.1% growth or $29 
over the study period. Within these 
categories, the highest out-of-pocket 
spending was on visits to the doctor 
($91 per teenager in 2014) and ER 
visits ($66; Appendix Table A37). 
Spending out of pocket on both of 
these services was higher for girls 
than for boys (Appendix Table A41). 
Out-of-pocket spending in 2014 on 
doctor visits was $101 per teen girl 
and $81 per teen boy (Appendix Ta-
bles A43 and A48). Out-of-pocket 
spending on ER visits was $72 per 
teen girl and $60 per teen boy. 
Compared to professional services 
and outpatient visits, there was slow-
er growth in out-of-pocket spending 
on acute inpatient admissions during 
the study period (Appendix Table 
A34). Out-of-pocket spending on 
acute admissions grew an average 
annual 5.0%, or just $4 per capita 
during the study period. Of the types 
of acute admission, only out-of-pocket 
spending on mental health and sub-
stance use (MH/SU) admissions in-
creased, growing from $7 per capita 
in 2010 to $12 per capita in 2014 
(Appendix Table A37). While out-of-
pocket spending on MH/SU admis-
sions increased for both teenage boys 
and girls during the study period, this 
increase was larger for girls. Between 
2010 and 2014, out-of-pocket spend-
ing on MH/SU admissions increased 
by $2 per teen boy and by $6 per teen 
girl (Appendix Tables A43 and A48).  
Out-of-pocket spending on generic 
prescriptions grew during the study 
period, from $47 in 2010 to $55 in 
2014 (Appendix Table A34). Howev-
er, this spending declined between 
2013 and 2014, by $2 per teenager, to 
$55 per teenager. During the study 
period, the most out-of-pocket dollars 
spent on generic prescriptions were 
for CNS agents ($19 per teen in 2014; 
Appendix Table A37). 
Out-of-pocket spending on brand pre-
scriptions declined throughout the 
study period, by an average annual 
5.6%, from $55 per teen in 2010 to 
$44 in 2014 (Appendix Table A34). As 
with generic prescriptions, more out-
of-pocket dollars were spent on brand 
CNS agents than any other type of 
brand prescriptions ($14 per teenag-
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er in 2014; Appendix Table A37). For 
boys, spending on brand CNS agents 
was $18 per teen boy in 2014, and 
this spending declined by $6 per teen 
boy between 2010 and 2014 
(Appendix Table A43). For girls, 
spending on brand CNS agents was 
$10 per teen girl, the same as spend-
ing on brand hormones and synthetic 
substitutes. Out-of-pocket spending 
on both of these types of brand pre-
scriptions declined throughout the 
study period, by $5 per teen girl for 
brand CNS agents and $7 for brand 
hormones and synthetic substitutes 
(Appendix Table A48). 
Utilization 
Similar to trends observed for pre-
teens, use of professional services and 
generic prescriptions by teenagers 
increased slightly in 2014 (Appendix 
Table A33). Use of professional ser-
vices increased in every year studied, 
but the smallest increase occurred in 
2014, as use increased by just 9 ser-
vices per 1,000 teenagers to 10,831 
per 1,000 teens. In 2014, there were 
also small increases in the use of la-
boratory/pathology services (an in-
crease of 45 services per 1,000 teen-
agers to 2,217 services) and adminis-
tered drugs (an increase of 1 service 
to 128 services per 1,000 teens; Ap-
pendix Table A36). At the same time 
the number of visits to doctors – the 
most used type of professional service 
by teenagers – declined slightly, by 16 
visits to 2,689 visits per 1,000 teenag-
ers. 
As with professional services, utiliza-
tion of generic prescriptions in-
creased slightly in 2014, by 2,557 
filled days per 1,000 teenagers 
(Appendix Table A33). This was the 
smallest year-on-year increase in use 
of generics observed during the study 
period. By 2014, use of generic pre-
scriptions increased to 91,353 filled 
days per 1,000 teenagers. Only the 
use of generic anti-infective agents 
declined in 2014, by 5.3% to 11,084 
filled days per 1,000 teens (Appendix 
Table A36). Use of all other types of 
generic prescriptions by teens in-
creased in 2013 and 2014.  
Use of all of the other medical sub-
service categories declined in 2014. 
This was the third year in a row that 
we observed a decline in acute admis-
sions (by 1 admission per 1,000 teen-
agers in 2014 to 26; Appendix Table 
A33). This was the second year of de-
clining use of outpatient visits (3 vis-
its per 1,000 teenagers in 2014 to 
230) and outpatient-other services (5 
services per 1,000 teenagers in 2014 
to 1,398).  
The decline in acute inpatient admis-
sions in 2014 was observed for both 
teenage boys and girls, but the decline 
was larger for girls: a decline of 1 ad-
mission per 1,000 teen boys as com-
pared to 2 admissions for girls 
(Appendix Table A44). Unlike for the 
other age groups where there were 
more admissions for boys than girls, 
there were many more acute inpa-
tient admissions for teen girls than 
for teen boys. The difference is due to 
labor and delivery admissions for 
teen girls (4 per 1,000 teen girls in 
2014) and more MH/SU admissions 
for teen girls. In 2014, there were 14 
MH/SU admissions per 1,000 teen 
girls compared to 9 per 1,000 teen 
boys (Appendix Tables A44 and A47). 
There was also a larger increase in 
the use of MH/SU admissions by girls; 
MH/SU admissions by girls increased 
by 4 admissions per 1,000 teen girls 
over the study period, as compared to 
an increase of 1 admission for boys. 
The decline in use of outpatient visits 
in 2014 was due to declines in the use 
of all types of visits. Use of ER visits, 
outpatient surgery visits, and obser-
vation visits each declined by 1 visit 
per 1,000 teenagers (Appendix Table 
A36). However, this decline in use of 
ER visits in 2014 was only observed 
for boys, whose use declined by 4 vis-
its per 1,000 teen boys to 163 visits 
(Appendix Table A44). At the same 
time, ER visits by girls increased by 2 
visits per 1,000 teen girls to 202 visits 
(Appendix Table A47). 
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The use of brand prescriptions de-
clined in every year studied: by 
14,336 filled days per 1,000 teenagers 
between 2010 and 2014 (Appendix 
Tables A33). In 2013 and 2014, use of 
all subcategories of brand prescrip-
tions declined. In 2014, the largest 
decline was in the use of brand CNS 
agents (-970 filled days per 1,000 
teenagers to 7,290) and brand hor-
mone and synthetic substitutes (-396 
per 1,000 teenagers to 4,691; Appen-
dix Tables A36).  
Between 2010 and 2014, use of brand 
prescriptions declined, while use of 
generic prescriptions increased. This 
year-on-year increase in generic use 
was larger than the decline in use of 
brand prescriptions, which led to a 
small net increase in prescription use 
in every year of the study period. 
However, in 2014, this increase in 
prescription use was only observed 
for girls (an increase of 2,196 filled 
days per 1,000 teen girls; Appendix 
Table A40 and Figure 15). Prescrip-
tion use by boys declined slightly in 
2014, by 1,650 filled days per 1,000 
teen boys. 
The net increase in prescription use 
between 2010 and 2014 was largely 
driven by net increases in the use of 
both CNS agents and hormones and 
synthetic substitutes (Appendix Ta-
bles A44 and A47). The net increase 
over the study period in use of CNS 
agents was observed for both boys 
(an increase of 4,240 filled days per 
1,000 teen boys to 39,042) and girls 
(8,145 filled days per 1,000 teen girls 
to 38,436). However, the net increase 
in use of hormones and synthetic sub-
stitutes was only observed for girls: 
an increase of 4,945 filled days per 
1,000 teen girls over the study period 
to 48,175 filled days in 2014. Over the 
same period, net use of hormones and 
synthetic substitutes by boys declined 
slightly, by 439 filled days per 1,000 
teen boys to 4,438 filled days in 2014.   
For girls, prescription use was domi-
nated by generic oral contraceptives 
(AHFS class 68:12.00). In 2014, teen 
girls used 34,405 filled days per 1,000 
teen girls, which was 25% of their 
total prescription use in that year 
(Appendix Table A56). The second 
most used type of prescription were 
generic antidepressants (AHFS class 
28:16.04), which made up 12% of 
girls’ total prescription use (16,545 
filled days per 1,000 teen girls in 
2014). Between 2010 and 2014, use 
of generic oral contraceptives in-
creased by 37% (9,283 filled days per 
1,000 teen girls) and use of generic 
antidepressants increased by 85% 
(7,624 filled days).  
For boys, the most used type of pre-
scription in 2014 was generic antide-
pressants (9,854 filled days per 1,000 
teen boys), which comprised 11% of 
their total prescription use (Appendix 
Table A56). Use of generic antidepres-
sants by teen boys increased by 52% 
between 2010 and 2014, which in-
creased by 3,386 filled days per 1,000 
teen boys. The second most used type 
of prescription by boys was generic 
respiratory and cerebral stimulants 
(AHFS class 28:20.32; a class of drugs 
that includes ADHD drugs, such as 
Ritalin), which comprised 7% of boys’ 
total prescription use (6,540 filled 
days per 1,000 teen boys).4  
Average Price Per Service 
The average price per service catego-
ry rose in every year studied for all of 
the medical service categories and for 
brand prescriptions (average price 
per filled day; Appendix Table A33 
and Figure 16).  
Outpatient-other services saw a mod-
est increase in the average price per 
service, just $34 per service between 
2010 and 2014 (Appendix Table A33). 
During the same time period, the av-
erage price of an outpatient visit in-
creased by over $515. This increase 
was largely due to an increase in out-
patient surgical visits (an increase of 
$1,282), although there were also 
increases in the average price of both 
ER visits ($365) and observation vis-
its ($482; Appendix Table A38). 
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The average price of a professional 
service increased only slightly – from 
$85 in 2010 to $93 in 2014 (an aver-
age annual 2.1% increase; Appendix 
Table A33 and Figure 16). Within the 
professional services category, the 
largest price increase was observed 
for administered drugs (Appendix 
Table A38). The average price in-
creased by $154 during that period, 
while use of these drugs increased 
only slightly (from 121 per 1,000 
teenagers in 2010 to 128 in 2014; 
Appendix Table A36). We also ob-
served a $72 increase in the average 
price of anesthesia (Appendix Table 
A38). Over the same period, the aver-
age price increases observed for la-
boratory/pathology and radiology 
professional services were small: av-
erage dollar increases of $1 and $4, 
respectively.  
During the study period, the average 
price per filled day of brand prescrip-
tions more than doubled, increasing 
from $8 per filled day in 2010 to $17 
in 2014, an average annual increase 
of 19.5% (Appendix Table A33 and 
Figure 16). The average price per 
filled day also more than doubled for 
brand hormones and synthetic substi-
tutes (a $12 per day increase), brand 
cardiovascular drugs (a $13 per day 
increase), and brand respiratory 
agents (a $7 per day increase; Appen-
dix Table A38). All other types of 
brand prescriptions also saw increas-
es in the average price per filled day, 
but these increases were more mod-
erate.  
For generic prescriptions, the average 
price per filled day remained steady 
at $2 throughout the study period 
(Appendix Table A33). Only generic 
skin and mucous membrane agents 
saw a sizable average price increase, 
from $4 per filled day in 2010 to $7 in 
2014 (Appendix Table A38).  
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Health Care Trends: Selected States 
For the first time, HCCI is presenting 
trends in the costs and utilization of 
health care for children (ages 0–18) 
by state. We have chosen ten states 
for which we have sufficient data to 
analyze trends at the state-level. The 
states discussed in this section are: 
Arizona, Connecticut, District of Co-
lumbia (DC), Florida, Illinois, Mary-
land, Ohio, Texas, Virginia, and Wis-
consin. We limited the selected states 
to ten that are relatively geograph-
ically distributed across the country, 
and these are for discussion purposes 
only. These states are not meant to be 
a representative sample of all states 
or of children in the states. 
Health Care Spending in Selected 
States 
Nationally, spending per child on 
health care in 2014 was $2,660 
(Appendix Table A57). The ten states 
studied skew slightly towards the 
higher end of per capita spending 
trends, and only four of the ten had 
per capita spending below the nation-
al average in 2014 (Figures 17 and 
18). Of the ten states analyzed, in 
2014, the lowest per capita spending 
was in Arizona: $2,151 per capita, or 
81% of national per capita spending. 
Arizona had the lowest per capita 
spending in each year studied. The 
highest per capita spending in 2014 
was observed for DC: $3,040 in 2014, 
or 114% of the national average. In 
comparison to other states in the DC 
area, Maryland had per capita spend-
ing of $2,316 (the second-lowest per 
capita spending in every year) and 
Virginia had spending of $2,617, $724 
and $423 per capita lower than 
spending in DC, respectively. Howev-
er, of these ten states DC only had the 
highest per capita spending in 2013 
and 2014. Prior to 2013, DC had the 
third lowest per capita spending, after 
Arizona and Maryland. In 2012, the 
highest spending per capita was ob-
served for Texas. In 2010 and 2011 
the highest spending per capita was 
observed for Wisconsin.  
Even though DC had the highest per 
capita spending in 2013 and 2014 of 
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the ten states studied, it had the low-
est out-of-pocket spending per capita 
in every year of the study period 
($362 per capita in 2014; Appendix 
Table A58). Due to the low out-of-
pocket spending, DC also had the low-
est out-of-pocket burden (measured 
as the percentage of total spending 
that is paid out of pocket) of any state: 
12% in 2014 as compared to the na-
tional average of 18%. Comparatively, 
Wisconsin had highest per capita out-
of-pocket spending of the ten states in 
every year. In 2014, the out-of-pocket 
burden was highest in Wisconsin and 
Arizona at 19%, exceeding the nation-
al average by 1%.  
Trends in Selected States 
Arizona: Arizona had the lowest per 
capita spending for children of all of 
the states studied in all years of the 
study period (Appendix Table A57 
and Figure 17). The most dollars per 
capita were spent on ER visits ($206 
per capita in 2014) followed by surgi-
cal inpatient admissions ($159 in 
2014; Appendix Table A59). Fewer 
dollars than the national average per 
capita were spent on those services in 
that year: $214 on ER visits and $182 
on surgical admissions nationally. 
Despite lower spending in Arizona on 
those two services, the utilization 
rates were quite similar to the nation-
al usage per 1,000 children. There 
were 179 ER visits per 1,000 children 
in Arizona (the lowest ER utilization 
rate of the 10 states examined; Figure 
19) compared to 177 nationally in 
2014 (Appendix Table A5). Arizona 
met the national average with 3 surgi-
cal admissions per 1,000 children 
(Appendix Tables A59 and A5). The 
lower spending in Arizona seems to 
be related to lower average prices for 
those two services rather than lower 
than average utilization rates. The 
price of an average ER visit in Arizona 
was 95% of the national average (or 
$57 lower in Arizona), and the price 
of an average surgical admission was 
91% of the national average (or 
$4,891 lower; Appendix Tables A59 
and A7).  
Connecticut: Spending per child in 
Connecticut tended to be slightly 
higher than the national average per 
child spending: $2,953 in Connecticut 
as compared to $2,660 nationally in 
2014 (Appendix Tables A57 and A1, 
Figure 17). Interestingly, the differ-
ence between Connecticut’s spending 
and the national average increased 
over the study period; spending in 
Connecticut was 104% of the national 
average in 2010 and 111% in 2014. 
Compared to the other states exam-
ined, children in Connecticut had 
more visits to the doctor (Appendix 
Table A60). There were 3,817 doctor 
visits per 1,000 children in 2014, 
about 18% more visits than the na-
tional average of 3,228 visits per 
1,000 children (Appendix Table A5). 
Connecticut also had higher prescrip-
tion use than the other states studied. 
In 2014, there were 84,800 filled days 
of prescriptions per 1,000 children 
(Appendix Table A60), 17% higher 
than the national average (72,439 
filled days; Appendix Table A5 and 
Figure 20). 
DC: The per capita spending trends in 
DC varied across the time period. In 
2010 and 2011, DC had spending that 
was lower than the national average: 
91% of the national average in 2010 
and 99% in 2011 (Appendix Table 
A57). However, between 2012 and 
2014, spending per capita in DC rose 
above the national average. By 2014, 
per capita spending in DC rose to 
114% of the national average (Figure 
17). An increase in the number of 
acute admissions was one contrib-
uting factor to the growth in spending 
over the study period. Between 2010 
and 2014, the number of acute inpa-
tient admissions increased from 50 
admits per 1,000 children to 64 
(Appendix Table A61). In contrast, of 
the states studied, the second most 
admissions in 2014 was in Texas, 
which had 44 admits per 1,000 chil-
dren (Appendix Table A66). One rea-
son for the high number of acute ad-
missions in DC as compared to the 
other states was the higher number of 
newborn admissions. In 2014, DC had 
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40 newborn admissions per 1,000 
children (Appendix Table A61), near-
ly double the national average (21 per 
1,000 children; Appendix Table A5). 
DC also saw the number of these ad-
missions increase by over 50% across 
the study period, from 27 per 1,000 
children in 2010 to 40 in 2014 
(Appendix Table A61). In comparison, 
nationally, the number of newborn 
admissions increased by just 2 admis-
sions per 1,000 children (from 19 to 
21, or an about 10% increase; Appen-
dix Table A5). Additionally, DC had 
the most ER visits per 1,000 children 
(267) in 2014 as compared to the oth-
er states examined (Figure 19; Appen-
dix Table A61). However, DC had the 
lowest total prescription use of the 
states studied: 54,253 filled days per 
1,000 children in 2014, or about 75% 
of the national average (72,439 filled 
days; Figure 20).    
Florida: The per capita spending on 
health care for children in Florida 
kept pace with the national average 
per capita spending during the study 
period; spending in Florida was 100% 
of the national average in 2013 and 
2014 (Appendix Table A57 and Figure 
17). Similarly, out-of-pocket spending 
per capita in Florida was similar to 
the national average: $478 in Florida 
and $472 nationally in 2014 
(Appendix Table A58). In Florida, the 
number of outpatient laboratory/
pathology services used was less than 
half of the national average use: 207 
services per 1,000 children in Florida 
in 2014 as compared to 428 national-
ly (Appendix Tables A62 and A5). 
Conversely, in 2014, Florida had 
much higher use of professional lab/
path services than the national aver-
age: 2,524 per 1,000 children in Flori-
da as compared to 1,764 nationally. A 
similar, although less pronounced, 
trend was also observed for outpa-
tient versus professional radiology 
services. These trends may indicate 
differences in the provider settings in 
which children seek care in Florida 
versus other states, and is an interest-
ing topic for further study. Additional-
ly, children in Florida had higher rates 
of ER usage than the national average 
and the third highest of the states ex-
amined (after DC and Ohio; Appendix 
Tables A61 and A65): 200 ER visits 
per 1,000 children in Florida and 177 
visits nationally in 2014 (Figure 19; 
Appendix Tables A62 and A5).  
Illinois: For both total spending per 
capita and out-of-pocket spending per 
capita, Illinois ranked in the middle of 
the 10 states studied. In 2014, total 
spending was $2,771 per child, or 
104% of the national average. Out-of-
pocket spending was $500 per child, 
with an out-of-pocket burden of 18% 
of total spending (Appendix Tables 
A57 and A58, Figure 17). Illinois was 
also in the middle of the pack for utili-
zation of each of the service catego-
ries (Appendix Table A63), and slight-
ly over the national average in use 
rates for each of the medical service 
categories (Appendix Table A2). Use 
of prescriptions in Illinois was slightly 
below than the national average, with 
71,839 filled days per 1,000 children 
in Illinois and 72,439 filled days na-
tionally in 2014 (Figure 20; Appendix 
Tables A63 and A2).  
Maryland: Compared to the other 
nine states analyzed, in Maryland we 
observed both the second lowest per 
capita spending and out-of-pocket per 
capita spending. Maryland had the 
second lowest per capita spending, 
after Arizona, in most years studied: 
$2,316 per child in 2014, or 87% of 
the national average (Appendix Ta-
bles A57 and Figure 18). The out-of-
pocket per capita spending was also 
the second lowest – after DC – in eve-
ry year studied: $370 in 2014, or 16% 
of total spending paid out of pocket 
(Appendix Table A58). Specifically, 
Maryland had comparatively low out-
of-pocket spending on ER visits and 
on visits to the doctor. In 2014, out-of
-pocket spending per child in Mary-
land was $35 on ER visits (Appendix 
Table A64), compared to $67 nation-
ally (Appendix Table A6). For visits to 
the doctor, in 2014, out-of-pocket 
spending was $82 per child in Mary-
land and $97 nationally (Appendix 
Tables A64 and A6).  
Ohio: In all years studied, total per 
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capita spending in Ohio was relatively 
higher than in most of the other 
states, and exceeded the national av-
erage. In 2014, spending was $2,936 
per child, or 110% of the national 
average spending (Appendix Table 
A57 and Figure 18). Similarly, out-of-
pocket spending per capita was also 
higher in Ohio than many of the other 
states studied, with an out-of-pocket 
burden of 18% in 2014 (Appendix 
Table A58). Compared to the other 
states examined, Ohio had the second 
most number of ER visits after DC 
(Figure 19). In 2014, there were 259 
ER visits per 1,000 children 
(Appendix Table A65), 46% higher 
than the national average of 177 visits 
per 1,000 children (Appendix Table 
A5). There were also more outpatient 
surgery visits per 1,000 children in 
Ohio than any other state studied 
(Appendix Table A65). In 2014, there 
were 50 surgical visits per 1,000 chil-
dren in Ohio as compared to the na-
tional average of 39 visits (Appendix 
Table A5).  
Texas: Spending per child in Texas 
was relatively higher as compared to 
the other nine states and the national 
average. In all years studied, Texas 
had the second highest per capita 
spending, except in 2012 when it had 
the highest spending of the states ex-
amined. In 2014, spending was 
$3,018 per child, or 113% of the na-
tional average spending (Appendix 
Table A57 and Figure 18). Similarly, 
Texas also had comparatively higher 
per capita out-of-pocket spending in 
all years: $548 per child in 2014 
(Appendix Table A58). There were 
more administered drugs used by 
children in Texas as compared to the 
other nine states. In 2014, there were 
149 administered drug services per 
1,000 children, compared to the na-
tional average of 96 administered 
drug services per 1,000 children 
(Appendix Table A5). Texas also had 
the highest use of prescription drugs 
by babies (ages 0–3) of any state stud-
ied. In 2014, there were 53,304 filled 
days of prescriptions per 1,000 babies 
(Appendix Table A66), over 18% 
higher than the national average use 
(45,351 filled days; Appendix Table 
A12). One thing influencing this trend 
was higher usage of anti-infective 
agents by babies in Texas than in the 
other nine states. In Texas in 2014, 
there were 16,548 filled days of anti-
infective agents per 1,000 babies 
(Appendix Table A66), a use rate 
nearly 40% higher than the national 
average (12,088 filled days per 1,000 
babies; Appendix Table A12).  
Virginia: In nearly all years studied, 
Virginia’s per capita spending for chil-
dren was below the national average 
(Figure 18). Only in 2012 was per 
capita spending in Virginia slightly 
above the national average ($2,503 
per child in Virginia and $2,458 na-
tionally; Appendix Table A57). Rela-
tively low spending on acute inpatient 
admissions contributed to Virginia’s 
relatively lower per capita spending. 
In 2014, spending on acute admis-
sions was $527 per child (Appendix 
Table A67), 14% lower than the na-
tional average ($612 per child; Ap-
pendix Table A4). Interestingly, the 
number of acute admissions in Virgin-
ia was the same as the national aver-
age: 40 admits per 1,000 children 
(Appendix Tables A67 and A4). This 
was the fewest admissions of any 
state studied here. Virginia also had 
fewer medical admissions than the 
other states analyzed, and slightly 
lower (9 medical admissions per 
1,000 children; Appendix Table A67) 
than the national average (10 medical 
admissions per 1,000 children; Ap-
pendix Table A5).    
Wisconsin: Wisconsin had higher per 
capita spending than the national av-
erage in every year (Appendix Table 
A57 and Figure 18). In 2010 and 
2011, Wisconsin had the highest 
spending of the ten states examined. 
Wisconsin also had the highest per 
capita out-of-pocket of the states 
studied in each year (Appendix Table 
A58). Contributing to the compara-
tively higher spending per capita in 
Wisconsin was higher per capita 
spending on professional services. In 
2014, spending on professional ser-
vices in Wisconsin was $1,406 per 
child (Appendix Table A68), $200 
greater than per child spending in the 
next highest state ($1,206 per child in 
Connecticut; Appendix Table A60). 
Interestingly, spending trends in Wis-
consin seem to be more related to 
price than to utilization. Wisconsin 
had the lowest use of professional 
services (10,448 services per 1,000 
children) as compared to the other 
states, but had the highest average 
price per service ($135; Appendix 
Table A68). One specific example is 
with visits to the doctor. In 2014, 
there were 2,899 doctor visits per 
1,000 children in Wisconsin, the few-
est visits of any state studied. Con-
versely, per child spending on visits to 
the doctor was $454, the second high-
est spending after Connecticut, which 
had the most visits to the doctor 
($467 per child and 3,829 visits per 
1,000 children; Appendix Table A60). 
In Wisconsin, use of prescriptions 
ranked in the middle of the ten states, 
and slightly (3%) above the national 
average: 74,290 filled days per 1,000 
children in Wisconsin and 72,439 
filled days nationally in 2014 
(Appendix Tables A68 and A2). Of the 
ten states studied, Wisconsin had the 
lowest proportion of their total pre-
scription use that was brand prescrip-
tions. In 2014, 15% of the filled days 
of prescriptions in Wisconsin were for 
brand prescriptions (Appendix Table 
A68), as compared to 25% in Texas 
(the highest percentage of the states 
studied; Figure 20) and 19% national-
ly (Appendix Table A2).  
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Data  
HCCI’s dataset contains several billion 
de-identified commercial health in-
surance claims for the years 2010 
through 2014. Three major health 
insurers contributed data to HCCI for 
the purposes of producing a national, 
multipayer, commercial health care 
claims database. These data include 
claims for individuals covered by 
group insurance (fully insured and 
administrative services only), individ-
ual insurance, and Medicare Ad-
vantage plans. The claims data include 
prices paid to providers by both in-
surers and insureds and details about 
the services used. Furthermore, 
HCCI’s claims data are compliant with 
the Health Insurance Portability and 
Accountability Act (HIPAA).  
For Children’s Health Spending: 2010–
2014, HCCI performed analysis on a 
subset of data for approximately 10.2 
million insureds per year (2010–
2014). This analytic subset consisted 
of all claims for insureds ages 0 
through 18 and covered by ESI. The 
data set used for this report repre-
sented about 25% of the privately 
insured children in the United States.  
Methods  
HCCI weighed the analytic subset us-
ing United States Census Bureau age-
gender geographic-based estimates of 
the ESI population to make the analyt-
ic subset representative of the nation-
al ESI population. Claims in the analyt-
ic subset from 2013 and 2014 were 
actuarially completed to account for 
claims that had been incurred but not 
adjudicated. Claims for years 2010 
through 2012 were not adjusted and 
were considered 100% adjudicated. 
HCCI used the weighted, actuarially 
completed dataset to estimate per 
capita health expenditures, average 
prices, and utilization of services for 
2010 through 2014. HCCI did not cor-
rect dollars for inflation; thus, all re-
ported expenditures and prices were 
in nominal dollars. 
HCCI analyzed four major categories 
of services, several subservice catego-
ries, and detailed service categories. 
Inpatient facility claims were from 
hospitals, skilled nursing facilities 
(SNFs), and hospices where detail was 
sufficient to identify an overnight stay 
by an insured. Outpatient facility 
claims did not entail an overnight stay 
and include observation and ER ser-
vices. Both outpatient and inpatient 
claims consisted of only the facility 
charges associated with such claims. 
Professional services (procedures) 
included claims billed by physicians 
and non-physicians according to the 
industry’s standard procedure coding 
practices. Prescription data are pre-
scriptions filled at both retail and mail 
order pharmacies.  
For a more detailed description of 
HCCI’s methodology and dataset, see 
the Analytic Methodology on HCCI’s 
Website.3 HCCI’s analytic methodolo-
gy underwent a number of changes to 
enhance reporting since the previous 
Children’s Health Spending: 2010–
2013 report. See the methodology 
document and the 2014 Health Care 
Cost and Utilization Report, both avail-
able on HCCI’s Website, for details on 
these changes.3,5 
Limitations 
This report, like all research, had sev-
eral limitations that affect the general-
izability and interpretation of the 
findings. For this reason, HCCI consid-
ers the work a starting point for anal-
ysis and research on individuals cov-
ered by ESI rather than as a conclu-
sive analysis of the ESI population’s 
effect on health care in the United 
States.  
First, our findings were estimates for 
the United States ESI population ages 
0 through 18 based on a sample of 
approximately 25% of these insured 
children. Second, the analysis and re-
sults were descriptive, and the find-
ings were not used to determine caus-
al relationships. Third, this report did 
not discuss the effect of individual or 
population health status, such as ex-
istence of chronic conditions.  
Suggested citation for this report:  
“Children’s Health Spending Report: 
2010–2014.” Health Care Cost Insti-
tute, Inc., May 2016. Web. 
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Trend to Note: Change in Prescription Utilization by Children 
Between 2010 and 2014, the utilization of prescriptions by infants and toddlers (“babies”, ages 0–3) and younger children 
(ages 4–8) declined. This decline was initially small but accelerated over time. By 2014, prescription utilization by babies 
had declined by 8,429 filled days per 1,000 babies, and by 5,370 filled days per 1,000 younger children. For both babies and 
younger children, declines in use across the time period were largely influenced in declines in use of hormones and 
synthetic substitutes and anti-infective agents (Appendix Tables A12 and A19). 
For pre-teens (ages 9–13), utilization of prescriptions increased slightly in 2011 and 2012; however, mirroring the trends in 
the youngest children, use by pre-teens declined in 2013 and 2014. Conversely to the trends for the three youngest age 
groups, utilization of prescriptions by teenagers (ages 14–18) increased in every year study. However, as seen in Figure 15, 
the increase in use was only by teenage girls (an increase of 2,196 filled days per 1,000 teenage girls), while use by teenage 
boys declined in 2014 (a decline of 1,650 filled days per 1,000 teen boys). The decline in use of prescriptions by teenage 
boys in 2014 was largely influenced by a decline in use of anti-infective agents and central nervous system (CNS) agents 
(Appendix Table A44). At the same time, the increase in use of prescriptions by teenage girls in 2014 was largely due to 
increases in use of CNS agents and hormones and synthetic substitutes (Appendix Table A47), specifically an increase in the 
use of generic antidepressants (a CNS agent) and generic oral contraceptives (a hormone and synthetic substitute; 
Appendix Table A56). 
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Notes: All data weighted to reflect the national, ESI population ages 0-18. 
Data from 2013 and 2014 adjusted using actuarial completion. 
